The role of Aurora kinase A in hepatocellular carcinoma: Unveiling the intriguing functions of a key but still underexplored factor in liver cancer
Cell Proliferation · 2024-08 · 57 (8)
DOI: 10.1111/cpr.13641 ↗At a glance
Übersichtsarbeit in Cell Proliferation, published online on 2024-04-08. Written by Luca Grisetti and 4 co-authors. Institution: Fondazione Italiana Fegato - ONLUS, Liver Cancer Unit, Trieste, Italy. Major MEDLINE topics: Aurora Kinase A, Carcinoma, Hepatocellular, Liver Neoplasms. Cited 36 times so far (Crossref); 152 references. The full text is freely available (open access, CC BY 4.0). Funded by: EU Grant C3B, Università degli Studi di Trieste, Dipartimento di Scenze della Vita, Department of Science and Technology (DOST)-PCHRD.
Abstract (original language)
Aurora Kinase A (AURKA) plays a central role as a serine/threonine kinase in regulating cell cycle progression and mitotic functions. Over the years, extensive research has revealed the multifaceted roles of AURKA in cancer development and progression. AURKA's dysregulation is frequently observed in various human cancers, including hepatocellular carcinoma (HCC). Its overexpression in HCC has been associated with aggressive phenotypes and poor clinical outcomes. This review comprehensively explores the molecular mechanisms underlying AURKA expression in HCC and its functional implications in cell migration, invasion, epithelial‐to‐mesenchymal transition, metastasis, stemness, and drug resistance. This work focuses on the clinical significance of AURKA as a diagnostic and prognostic biomarker for HCC. High levels of AURKA expression have been correlated with shorter overall and disease‐free survival in various cohorts, highlighting its potential utility as a sensitive prognostic indicator. Recent insights into AURKA's role in modulating the tumour microenvironment, particularly immune cell recruitment, may provide valuable information for personalized treatment strategies. AURKA's critical involvement in modulating cellular pathways and its overexpression in cancer makes it an attractive target for anticancer therapies. This review discusses the evidence about novel and selective AURKA inhibitors for more effective treatments for HCC.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Fondazione Italiana Fegato - ONLUS, Liver Cancer Unit, Trieste, Italy.
- Department of Life Sciences, Università degli Studi di Trieste, Trieste, Italy.
ORCID profiles: Devis Pascut
Funding
- EU Grant C3B
- Università degli Studi di Trieste, Dipartimento di Scenze della Vita
- Department of Science and Technology (DOST)-PCHRD
- Programma di cooperazione Interreg V-A Italia -Slovenia 2014-2020
- Italian Liver Foundation
- Università degli Studi di Trieste
- Department of Science and Technology, Republic of the Philippines
- Fondazione Italiana Fegato Onlus
Cite
APA
Grisetti, L., Garcia, C. J. C., Saponaro, A. A., Tiribelli, C., & Pascut, D. (2024). The role of Aurora kinase A in hepatocellular carcinoma: Unveiling the intriguing functions of a key but still underexplored factor in liver cancer. Cell Proliferation, 57(8). https://doi.org/10.1111/cpr.13641
Vancouver
Grisetti L, Garcia CJC, Saponaro AA, Tiribelli C, Pascut D. The role of Aurora kinase A in hepatocellular carcinoma: Unveiling the intriguing functions of a key but still underexplored factor in liver cancer. Cell Proliferation. 2024;57(8). doi:10.1111/cpr.13641
BibTeX
@article{Grisetti2024,
author = {Grisetti, Luca and Garcia, Clarissa J C and Saponaro, Anna A and Tiribelli, Claudio and Pascut, Devis},
title = {The role of Aurora kinase A in hepatocellular carcinoma: Unveiling the intriguing functions of a key but still underexplored factor in liver cancer},
journal = {Cell Proliferation},
year = {2024},
volume = {57},
number = {8},
doi = {10.1111/cpr.13641}
}
EUVIMED